References
Naito M, Michelson EL, Kmetzo JJ, et al. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.Circulation 1981;63:70–79.
Schmid JR, Hanna C. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999 with quinidine and pronethalol.J Pharm Exper Ther 1967;156:331–338.
Lie KI, Wellens HJ, Van Capelle FJ, et al. Lidocaine in the prevention of primary ventricular fibrillation.New England J Med 1974;291:1324–1326.
Liberthson RR, Nagel EL, Hirschman JC, et al. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death.Circulation 1974;49:790–798.
Osler W.The Principles and Practice of Medicine. New York: D. Appleton and Co, 1892. Pp. 640–641.
Warnes CA, Roberts WC. Sudden coronary death: Comparison of patients with to those without coronary thrombus at necropsy.Am J Cardiol 1984;54:1206–1211.
Haerem JW. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death.Atherosclerosis 1974;19:529–541.
Yasue H, Omote S, Takizawa A, et al. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina.Circulation 1979;59:938–943.
Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death.Circulation 1987;75:131–138.
Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: Overview of the randomized trials.Progress in Cardiovascular Disease 1985;25:335–371.
Vandepol CJ, Farshidi A, Spielman SR, et al. Incidence and clinical significance of induced ventricular tachycardia.Am J Cardiol 1980;45:725–731.
Mason JW, Swerdlow CD, Winkle RA, et al. Ventricular tachyarrhythmia induction for drug selection: Experience with 311 patients.Perspectives in Cardiovascular Research 1984;10:229–239.
Kastor JA, Horowitz LN, Harken AH, et al. Clinical electrophysiology of ventricular tachycardia.New England J Med 1981;304:1004–1020.
Mason JW, Winkle RA. Accuracy of the ventricular tachycardia induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs.New England J Med 1980;303:1073–1077.
Ruskin JN, DiMarco JP, Garan H. Out of hospital cardiac arrest: Electrophysiologic observations and selection of longterm antiarrhythmic therapy.New England J Med 1983;303:607–613.
Thompson RG, Hallstrom AP, Cobb LA. Bystander-initiated cardiopulmonary resuscitation in the management of ventricular fibrillation.Annals of Internal Medicine 1979;90:737–740
Gudjonsson H, Balvinsson E, Oddsson G, et al. Results of attempted cardiopulmonary resuscitation of patients dying suddenly outside the Hospital in Reykjavik and the surrounding area, 1976–1979.Acta Med Scand 1982;212:247–251.
Myerburg RJ, Conde CA, Sung RJ, et al. Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest.Am J Med 1980;68:568–576.
Clusin WT, Bristow MR, Baim DS, et al. The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog.Circ Res 1982;518–526.
Clusin WT, Buchbinder M, Ellis AK, et al. Reduction of ischemic depolarization by the calcium channel blocker diltiazem: Correlation with improvement of ventricular conduction and early arrhythmias in the dog.Circ Res 1984;54:10–20.
Opie LH. Calcium, calcium ions and cardiovascular disease.Perspectives in Cardiovascular Research 1984;9:1–8.
Clusin WT, Buchbinder M, Harrison DC. Calcium overload, “injury” current, and early ischaemic cardiac arrhythmias—a direct connection.Lancet 1983;i:272–274.
Blake K, Smith NA, Clusin WT. Rate-dependence of ischemic myocardial depolarization—Evidence for a novel membrane current.Cardiovascular Research 1986;20:557–562.
Scherlag BJ, El-Sharif N, Hope R, Lazzara R. Characterization and localization of ventricular arrhythmias resulting from myocardial ischemia and infarction. 1974;35:372–377.
Clusin WT, Opie LH, Thandroyen, et al. Drastic reduction of cardiac work fails to mimic the antifibrillatory effect of low calcium.Circulation 1984;70II:346.
Tommaso C, Kehoe R, Zheutlin T. Survivors of ischemia-mediated sudden death: Clinical, angiographie and electrophysiologic features and response to therapy.Circulation 1982;66:II-25.
Kaumann AJ, Aramendia P. Prevention of ventricular fibrillation induced by coronary ligation.J Pharmacol Exp Ther 1968;164:326–332.
Blake K, Clusin WT Reduction of ischemic myocardial depolarization and extracellular potassium accumulation by diltiazem.Eur J Pharmacol 1986;127:261–265.
Fleet WF, Johnson TA, Graebner C, et al. Effects of verapamil on ischemia-induced changes in extracellular K+, pH, and local activation in the pig.Circulation 1985;107:II-125.
Lessem J. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.Cardiology 1982;69:199–208.
Hung J, Lamb I, Connolly S, et al. Effects of diltiazem, propranolol and their combination on exercise performance and ventricular function in stable effort angina: A randomized placebo study.Circulation 1982;66:II-32.
van Gilst WH, Kingma JH, Terpstra JA, et al. Post-exercise ventricular arrhythmias reduced by the calcium entry blocker diltiazem.J Am Coll Cardiol 1987;9:228A.
Opie LH. Products of myocardial ischemia and electrial instability of the heart.J Am Coll Cardiol 1985;6:162B-165B.
Yusuf S, Furberg C. Effect of acute or chronic administration of calcium antagonists on mortality following myocardial infarction.Am J Cardiol 1987;9:24A.
Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-q-wave myocardial infarction: Results of a double-blind, randomized, multicenter trial.New England J Med 1986;315:423–429.
Author information
Authors and Affiliations
Additional information
The author is supported by grants from the National Institutes of Health (HL06761) and by an Established Investigatorship of the American Heart Association.
Rights and permissions
About this article
Cite this article
Clusin, W.T. What is the solution to sudden cardiac death: Calcium modulation or arrhythmia clinics?. Cardiovasc Drug Ther 1, 335–342 (1987). https://doi.org/10.1007/BF02209072
Issue Date:
DOI: https://doi.org/10.1007/BF02209072